AG
Artal Group Portfolio holdings
AUM
$930M
This Quarter Return
+9.46%
1 Year Return
-3.57%
3 Year Return
+157.23%
5 Year Return
+160.22%
10 Year Return
+1,359.85%
AUM
$3.03B
AUM Growth
+$3.03B
(+3.1%)
Cap. Flow
+$76.1M
Cap. Flow
% of AUM
2.51%
Top 10 Holdings %
Top 10 Hldgs %
46.17%
Holding
153
New
22
Increased
19
Reduced
69
Closed
16
Top Buys
| 1 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$83M |
| 2 |
KLRS
Kalaris Therapeutics, Inc. Common Stock
KLRS
|
$63.9M |
| 3 |
KE Holdings
BEKE
|
$53.3M |
| 4 |
IGMS
IGM Biosciences
IGMS
|
$50.8M |
| 5 |
iTeos Therapeutics
ITOS
|
$27M |
Top Sells
| 1 |
BPMC
Blueprint Medicines
BPMC
|
$42.9M |
| 2 |
PayPal
PYPL
|
$34.8M |
| 3 |
Avantor
AVTR
|
$34M |
| 4 |
argenx
ARGX
|
$33M |
| 5 |
Zillow
Z
|
$28.7M |
Sector Composition
| 1 | Healthcare | 78.37% |
| 2 | Consumer Discretionary | 13.95% |
| 3 | Technology | 3.4% |
| 4 | Real Estate | 1.76% |
| 5 | Materials | 1.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Spero Therapeutics
SPRO
$116M
| $6.7M | 0.16% | 600,000 +54,960 | +10% | +$613K |
|
|
ARAV
77
DELISTED
Aravive, Inc. Common Stock
ARAV
| $6.16M | 0.15% | 1,311,291 -69,015 | -5% | -$324K |
|
78
Regenxbio
RGNX
$451M
| $6.12M | 0.15% | 222,300 -11,700 | -5% | -$322K |
|
79
ProQR Therapeutics
PRQR
$237M
| $5.73M | 0.14% | 1,196,218 -62,959 | -5% | -$302K |
|
|
HOOK
80
DELISTED
HOOKIPA Pharma
HOOK
| $5.68M | 0.14% | 599,616 | – | – |
|
81
Leap Therapeutics
LPTX
$12M
| $5.59M | 0.14% | 2,825,300 -148,700 | -5% | -$294K |
|
|
KLDO
82
DELISTED
Kaleido Biosciences, Inc. Common Stock
KLDO
| $5.54M | 0.13% | 500,500 | – | – |
|
|
ALPN
83
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
| $5.21M | 0.13% | +593,030 | New | +$5.21M |
|
|
APTX
84
DELISTED
Aptinyx Inc. Common Stock
APTX
| $5.08M | 0.12% | 1,502,035 -79,055 | -5% | -$267K |
|
|
VXRT
85
DELISTED
Vaxart
VXRT
| $4.99M | 0.12% | 750,000 +550,000 | +275% | +$3.66M |
|
86
AC Immune
ACIU
$205M
| $4.88M | 0.12% | 1,000,000 +15,450 | +2% | +$75.4K |
|
87
Adaptive Biotechnologies
ADPT
$2.01B
| $4.86M | 0.12% | 100,000 -88,000 | -47% | -$4.28M |
|
|
AXDX
88
DELISTED
Accelerate Diagnostics
AXDX
| $4.56M | 0.11% | 427,500 -159,000 | -27% | -$1.69M |
|
|
SYRS
89
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $4.12M | 0.1% | 465,500 -24,500 | -5% | -$217K |
|
|
YI
90
111 Inc
YI
$55.7M
| $4.03M | 0.1% | 650,000 | – | – |
|
91
Avidity Biosciences
RNA
$5.99B
| $4.01M | 0.1% | 142,500 -32,500 | -19% | -$915K |
|
92
Intellia Therapeutics
NTLA
$1.22B
| $3.78M | 0.09% | 190,000 -49,000 | -21% | -$974K |
|
93
ALX Oncology
ALXO
$62.7M
| $3.77M | 0.09% | +100,000 | New | +$3.77M |
|
94
Occidental Petroleum
OXY
$46.9B
| $3.75M | 0.09% | +375,000 | New | +$3.75M |
|
95
Oric Pharmaceuticals
ORIC
$994M
| $3.56M | 0.09% | 142,500 -7,500 | -5% | -$188K |
|
96
Prothena Corp
PRTA
$441M
| $3.51M | 0.09% | 351,500 -18,500 | -5% | -$185K |
|
97
Solid Biosciences
SLDB
$427M
| $3.47M | 0.08% | 1,710,000 -90,000 | -5% | -$183K |
|
|
AUTL
98
Autolus Therapeutics
AUTL
$399M
| $3.32M | 0.08% | 285,000 -115,000 | -29% | -$1.34M |
|
|
AXLA
99
DELISTED
Axcella Health Inc. Common Stock
AXLA
| $3.29M | 0.08% | 712,500 -187,500 | -21% | -$866K |
|
100
ADC Therapeutics
ADCT
$345M
| $3.13M | 0.08% | 95,000 -41,000 | -30% | -$1.35M |
|